In this systematic review and meta‐analysis of 5 RCTs and 2019 individuals, we sought to compare the safety and efficacy of once‐weekly insulin icodec with once‐daily insulin glargine U100 in individuals with T2D. Here, INS is linked to type 2 diabetes mellitus.